[Action of synkavit on conversion of 3-hydroxyanthranilic acid to quinolinic acid].
D015095:3-Hydroxyanthranilic Acid; D062365:Aminobenzoates / Q000378:metabolism*; D000933:Antifibrinolytic Agents; D002273:Carcinogens / Q000378:metabolism*; D011725:Pyridines / Q000378:metabolism*; D017378:Quinolinic Acid; D014812:Vitamin K / Q000494:pharmacology* / Q000031:analogs & derivatives
D062365:Aminobenzoates; D000933:Antifibrinolytic Agents; D002273:Carcinogens; D011725:Pyridines; D014812:Vitamin K; D015095:3-Hydroxyanthranilic Acid; D017378:Quinolinic Acid; C023885:menadiol
AMINOBENZOATES/metabolism; CARCINOGENS/metabolism; PYRIDINES/metabolism; VITAMIN K/effects
Azione del synkavit (2-metil-1, 4-naftoidrochinone difosfato di sodio) sulla conversione acido 3-idrossiantranilico acido chinolinico.